These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4278576)

  • 21. [Metabolism of proteoglykans in progressive sclerodermia].
    Kreysel H; Kleine TO; Köhler N
    Verh Dtsch Ges Inn Med; 1972; 78():1584. PubMed ID: 4269221
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathogenesis of skin scleroderma--literature review].
    Wojas-Pelc A; Lipko-Godlewska S
    Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus.
    Norton WL
    Lab Invest; 1970 Apr; 22(4):301-8. PubMed ID: 5429531
    [No Abstract]   [Full Text] [Related]  

  • 24. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
    Lukasiak B; Szczepański A; Rózański J; Wnorowski J
    Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic scleroderma and massive infarction of intestine and liver.
    MacMahon HE
    Surg Gynecol Obstet; 1972 Jan; 134(1):10-4. PubMed ID: 5007169
    [No Abstract]   [Full Text] [Related]  

  • 26. Skin blood flow in scleroderma.
    Coffman JD
    J Lab Clin Med; 1970 Sep; 76(3):480-4. PubMed ID: 4917795
    [No Abstract]   [Full Text] [Related]  

  • 27. [The evolution of the concepts of systemic scleroderma].
    Guseva NG
    Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
    [No Abstract]   [Full Text] [Related]  

  • 28. [Developing a clinical classification of systemic scleroderma].
    Guseva NG
    Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential benefit of statins for vascular disease in systemic sclerosis.
    Kuwana M
    Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
    Derk CT; Jimenez SA
    Autoimmun Rev; 2006 Jan; 5(1):25-32. PubMed ID: 16338208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma.
    Blumenkrantz N; Asboe-Hansen G
    Acta Derm Venereol; 1980; 60(1):39-43. PubMed ID: 6153832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormones--underestimated problem in dermatology. Part 2. Autoimmune disease].
    Damasiewicz-Bodzek A; Kos-Kudła B
    Pol Merkur Lekarski; 2002 Jun; 12(72):546-50. PubMed ID: 12362680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation of bone pathology to vascular changes].
    SEYSS R
    Radiol Clin; 1954 May; 23(3):129-36. PubMed ID: 13186100
    [No Abstract]   [Full Text] [Related]  

  • 34. Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis.
    Manetti M
    Exp Dermatol; 2015 Apr; 24(4):256-7. PubMed ID: 25529866
    [No Abstract]   [Full Text] [Related]  

  • 35. The development of systemic sclerosis (scleroderma) following augmentation mammoplasty.
    Appleton BE; Lee P
    J Rheumatol; 1993 Jun; 20(6):1052-4. PubMed ID: 8350312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progressive systemic sclerosis. A diagnostic problem].
    Posada de la Paz M; Martínez L de Letona J; Masa Vázquez C; Ruiz Galiana J; Pérez Alvarez R; Díez García F; Pérez Maestu R
    Rev Clin Esp; 1983 Sep; 170(6):237-41. PubMed ID: 6361922
    [No Abstract]   [Full Text] [Related]  

  • 37. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
    Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
    Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local regulation of blood flow in cutaneous and subcutaneous tissue in patients with generalized scleroderma.
    Kristensen JK
    Acta Derm Venereol Suppl (Stockh); 1980; Suppl 90():1-39. PubMed ID: 6932795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis of systemic scleroderma--new evidence].
    Rudnicka L; Majewski S
    Przegl Dermatol; 1990; 77(6):417-21. PubMed ID: 2287746
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics of clinical symptoms and course of systemic scleroderma depending on sex and age of onset].
    Volkov AV; Starovoĭtova MN; Guseva NG
    Ter Arkh; 2004; 76(5):7-11. PubMed ID: 15230123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.